Company intelligence / Profile preview

GBRL Consulting

Alpharetta, Georgia, USA

Ownership: Private
Development stage: Other

Overview

GBRL Consulting, LLC, operating as AdviseDX, provides specialized consulting and management services in the pathology and diagnostics sector. The company was acquired by Fulgent Genetics in December 2025 as part of a $43 million asset purchase involving the Bako Pathology group.

Therapeutic areas: OtherDermatology
Modalities: Diagnostics
Industry: Consulting

Partnerships

Inform DiagnosticsBakotic Pathology AssociatesPodceuticals

Beyond the preview

Go deeper on GBRL Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GBRL Consulting.

Explore the full profile